STOCK TITAN

Maravai Lifesciences (MRVI) CFO has 5,465 shares withheld for taxes

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Maravai Lifesciences Holdings, Inc. reported that Chief Financial Officer Rajesh Asarpota had 5,465 shares of Class A Common Stock withheld on July 30, 2026, at $6.59 per share to satisfy tax withholding obligations related to the vesting of restricted stock unit awards. After this tax-withholding disposition, he directly holds 428,951 shares. The transaction was not reported as made pursuant to a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider Asarpota Rajesh
Role Chief Financial Officer
Type Security Shares Price Value
Tax Withholding Class A Common Stock F1 5,465 $6.59 $36K
Holdings After Transaction: Class A Common Stock — 428,951 shares (Direct)
Footnotes (1)
  1. F1. Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.
Shares withheld for taxes 5,465 shares Shares of Class A Common Stock withheld on July 30, 2026 for tax obligations
Per-share value for tax withholding $6.59 per share Value used for the tax-withholding disposition on July 30, 2026
Shares held after transaction 428,951 shares Direct Class A Common Stock holdings of CFO Rajesh Asarpota following the tax-withholding transaction
restricted stock unit awards financial
"in connection with the vesting of restricted stock unit awards held"
Restricted stock unit awards are company promises to deliver a specific number of shares to employees or service providers in the future once conditions—such as staying with the company for a set time or meeting performance targets—are met. They matter to investors because when the promises convert into actual shares they increase the total share count and can reduce earnings per share, while also aligning recipients’ interests with stock performance much like deferred pay that turns into ownership if goals are met.
tax withholding obligations financial
"Represents shares withheld to satisfy tax withholding obligations in connection"
Class A Common Stock financial
"security_title": "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did MRVI CFO Rajesh Asarpota report?

Maravai Lifesciences CFO Rajesh Asarpota reported a tax-withholding disposition of 5,465 shares of Class A Common Stock on July 30, 2026. The shares were withheld to cover tax obligations from vesting restricted stock unit awards, rather than being sold in a market transaction.

How many Maravai Lifesciences (MRVI) shares were withheld for taxes?

A total of 5,465 shares of Maravai Lifesciences Class A Common Stock were withheld to satisfy tax withholding obligations. This withholding occurred in connection with the vesting of restricted stock unit awards held by CFO Rajesh Asarpota on July 30, 2026.

At what price were MRVI shares valued for the tax-withholding transaction?

The withheld shares were valued at $6.59 per share for the tax-withholding disposition. This per-share value was used to satisfy the tax obligations associated with the vesting of restricted stock unit awards held by Maravai Lifesciences CFO Rajesh Asarpota.

How many MRVI shares does the CFO hold after this tax-withholding event?

Following the tax-withholding disposition, CFO Rajesh Asarpota directly holds 428,951 shares of Maravai Lifesciences Class A Common Stock. This figure reflects his reported direct ownership immediately after the 5,465 shares were withheld for tax obligations on RSU vesting.

Was the MRVI CFO’s tax-withholding transaction under a Rule 10b5-1 plan?

The transaction was not reported as being made pursuant to a Rule 10b5-1 trading plan. The Rule 10b5-1 checkbox was not affirmed, indicating the tax-withholding disposition of 5,465 shares was not executed under a pre-arranged trading arrangement.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Asarpota Rajesh

(Last)(First)(Middle)
C/O MARAVAI LIFESCIENCES HOLDINGS, INC.
10770 WATERIDGE CIRCLE, SUITE 200

(Street)
SAN DIEGO CALIFORNIA 92121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MARAVAI LIFESCIENCES HOLDINGS, INC. [ MRVI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock07/30/2026F5,465(1)D$6.59428,951D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.
Remarks:
/s/ Kurt Oreshack, by power of attorney for Rajesh Asarpota07/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)